MetaADEDB 2.0 @ LMMD
Methyclothiazide
(CESYKOGBSMNBPD-UHFFFAOYSA-N)
Structure
SMILES
ClCC1Nc2cc(Cl)c(cc2S(=O)(=O)N1C)S(=O)(=O)N
Type(s)
Approved
ATC code(s)
C03AA08; C03AB08; G01AE10
Molecular Formula:
C9H11Cl2N3O4S2
Molecular Weight:
360.237
Log P:
3.5361
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
2
TPSA:
126.33
CAS Number(s):
135-07-9
Synonym(s)
1.
Methyclothiazide
External Link(s)
MeSHD008736
PubChem Compound4121
ChEBI6847
CHEMBLCHEMBL1577
DrugBankDB00232
DrugCentral1759
IUPHAR/BPS Guide to PHARMACOLOGY7235
KEGGcpd:C07765
dr:D00656
Therapeutic Target DatabaseD03GVC
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1GoutFAERS: 1US FAERS
2AgitationSIDER
3AgranulocytosisSIDER
4Anaphylactic shockSIDER
5Anorexia4942478CTD
SIDER
6AstheniaCanada Vigilance: 1Canada Vigilance
SIDER
7Blood urea increasedCanada Vigilance: 1Canada Vigilance
8ConstipationSIDER
9DermatitisSIDER
10DizzinessCanada Vigilance: 1Canada Vigilance
SIDER
11Electrolyte imbalanceSIDER
12Epigastric discomfortSIDER
13Erythema MultiformeSIDER
14Fatigue4942478CTD
15Gastric irritationSIDER
16GlycosuriaSIDER
17HeadacheSIDER
18HypersensitivitySIDER
19LeukopeniaSIDER
20MalnutritionSIDER
21NauseaCanada Vigilance: 24942478CTD
SIDER
Canada Vigilance
22PancreatitisSIDER
23PneumoniaSIDER
24PurpuraSIDER
25Respiratory distressSIDER
26Stevens-Johnson SyndromeSIDER
27ThrombocytopeniaSIDER
28UrticariaSIDER
29Vascular purpuraSIDER
30VasculitisSIDER
31VertigoCanada Vigilance: 1Canada Vigilance
SIDER
32VomitingSIDER
33XanthopsiaSIDER
34jaundiceSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120242

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.